Qi Yi Luo
Directeur/Membre du Conseil chez MICROPORT SCIENTIFIC CORPORATION
Fortune : 5 M $ au 30/04/2024
Postes actifs de Qi Yi Luo
Sociétés | Poste | Début | Fin |
---|---|---|---|
MICROPORT SCIENTIFIC CORPORATION | Directeur/Membre du Conseil | 30/08/2023 | - |
Directeur Technique/Scientifique/R&D | 01/01/2003 | 30/08/2023 | |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Directeur/Membre du Conseil | 28/04/2020 | - |
Historique de carrière de Qi Yi Luo
Anciens postes connus de Qi Yi Luo
Sociétés | Poste | Début | Fin |
---|---|---|---|
SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Directeur/Membre du Conseil | - | 15/09/2023 |
MICROPORT CARDIOFLOW MEDTECH CORPORATION | Directeur/Membre du Conseil | 05/08/2019 | 16/01/2020 |
Président | 16/01/2020 | 29/08/2023 | |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Président | 01/05/2015 | 29/08/2023 |
Vas-Cath, Inc.
Vas-Cath, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Vas-Cath, Inc. is a Canadian company that specializes in catheters for hemodialysis. The private company is based in Mississauga, Canada. Vas-Cath was acquired by Bard Canada, Inc. on December 05, 1994. | Directeur/Membre du Conseil | 01/01/1991 | 01/01/1995 |
Formation de Qi Yi Luo
Queen's University | Graduate Degree |
Yunnan Technology & Business University | Undergraduate Degree |
University of Shanghai for Science & Technology | Doctorate Degree |
Statistiques
Internationale
Chine | 6 |
Canada | 3 |
Îles Cayman | 3 |
Opérationnelle
Director/Board Member | 5 |
Chairman | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
MICROPORT SCIENTIFIC CORPORATION | Health Technology |
SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Commercial Services |
MICROPORT CARDIOFLOW MEDTECH CORPORATION | Health Technology |
Entreprise privées | 3 |
---|---|
Vas-Cath, Inc.
Vas-Cath, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Vas-Cath, Inc. is a Canadian company that specializes in catheters for hemodialysis. The private company is based in Mississauga, Canada. Vas-Cath was acquired by Bard Canada, Inc. on December 05, 1994. | Health Technology |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Health Technology |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Finance |